Condition: Anaplastic Ependymoma · Ependymoma · Sponsor: M.D. Anderson Cancer Center
This phase I trial studies the side effects of linear energy transfer (LET) optimized image modulated proton therapy (IMPT) in treating pediatric patients with ependymoma. Radiation therapy such as LET optimized IMPT, uses proton beams to kill tumor cells and shrink tumors without damaging surrounding normal tissues.
This description comes directly from the study's public registry record.
David Grosshans · 713-563-2300 · dgrossha@mdanderson.org
Always discuss trial participation with your own doctor first.
| Massachusetts General Hospital Cancer Center | Boston, Massachusetts, United States | Not Yet Recruiting |
| M D Anderson Cancer Center | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03750513